Biotech Values

[pcrutch]

Talk about a blatant freaking lie. I may buy some speculative $TEVA puts; they'd be worth gold bars if $MNTA gets positive outcome in legal proceedings and/or FDA approval.

“Any so-called generic Copaxone is, at the very earliest, years away,”[WE disagree!] Chief Executive Officer Shlomo Yanai said on a conference call yesterday. “We are taking the right strategic and operational measures and making the right investments to keep us on track.”